XETRA - Delayed Quote EUR

Thermo Fisher Scientific Inc. (TN8.DE)

372.55
-23.20
(-5.86%)
At close: April 24 at 5:35:44 PM GMT+2

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Marc N. Casper Chairman, President & CEO 6.87M 67.83M 1968
Mr. Stephen Williamson Senior VP & CFO 2.66M 7.37M 1967
Mr. Michel Lagarde Executive VP & COO 2.93M 8.56M 1975
Mr. Frederick M. Lowery Executive VP and President of Laboratory Product & BioProduction 2.05M -- 1971
Mr. Gianluca Pettiti Executive VP and President of Life Science, Diagnostics & Applied 2.36M -- 1979
Mr. Joseph R. Holmes VP & Chief Accounting Officer -- -- 1980
Mr. Ryan J. Snyder Senior VP & Chief Information Officer -- -- --
Dr. Karen E. Nelson Ph.D. Chief Scientific Officer -- -- --
Mr. Rafael Tejada Vice President of Investor Relations -- -- --
Mr. Michael A. Boxer Esq. Senior VP & General Counsel 1.55M 2.56M 1962

Thermo Fisher Scientific Inc.

168 Third Avenue
Waltham, MA 02451
United States
781 622 1000 https://www.thermofisher.com
Sector: 
Healthcare
Full Time Employees: 
125,000

Description

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment includes clinical diagnostics offering liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics offers develops, manufactures, and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; microbiology offers dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; transplant diagnostics products include human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel offers consumables, diagnostic kits and reagents, equipment, instruments, solutions, and services. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Corporate Governance

Thermo Fisher Scientific Inc.’s ISS Governance QualityScore as of April 1, 2025 is 2. The pillar scores are Audit: 2; Board: 6; Shareholder Rights: 1; Compensation: 5.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

July 22, 2025 at 12:30 PM UTC - July 28, 2025 at 12:30 PM UTC

Thermo Fisher Scientific Inc. Earnings Date

Recent Events

March 14, 2025 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers